Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bvf Inc/il
Relationship:   Indirect Beneficial Ow...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   49,829,941    

Indirect Shares

   136,880,248      
Direct Value   $2,543,238,041    

Indirect Value

   $7,621,871,799      
Total Shares   186,710,189      
Total Value   $10,165,109,840      


Neurocrine Biosciences Inc $587,278,161 Neurobiological Technologies Inc $33 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $46,511,110 Ligand Pharmaceuticals Inc $1,510,016,823 Curis Inc $3,390,252 Repligen Corp $394,987,393 Gyre Therapeutics $1,054,262 Neurocrine Biosciences Inc $587,278,161 Neurobiological Technologies Inc $33 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $46,511,110 Ligand Pharmaceuticals Inc $1,510,016,823 Curis Inc $3,390,252 Repligen Corp $394,987,393 Gyre Therapeutics $1,054,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    19   
    2    

     Stock price went up :
    18   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   18.0   
   -2.0   
     Percentage Gain/Loss :
   64.8%
 -200.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX 10% Owner 2010-04-12 5,041,447 2010-04-12 15,124,341    Premium*  
            NPS Pharmaceuticals Inc NPSP Indirect Beneficial Ow... 2008-03-11 0 2008-09-22 4,383,115    Premium*  
            Astex Pharmaceuticals Inc ASTX Indirect Beneficial Ow... 2008-05-01 0 2008-05-09 5,753,399    Premium*  
            Neurobiological Technologies Inc NTII 10% Owner 2009-10-21 331,998 2009-10-21 995,994    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 2009-12-22 6,830,972 2009-12-22 20,492,916    Premium*  
            Capstone Therapeutics Corp CAPS Indirect Beneficial Ow... 2008-10-10 0 2008-10-14 5,136,888    Premium*  
            Adolor Corp ADLR Indirect Beneficial Ow... 2008-10-10 4,428,032 2008-10-31 6,214,551    Premium*  
            Dynavax Technologies Corp DVAX 10% Owner 2009-09-10 4,278,851 2009-09-10 12,836,553    Premium*  
            Ligand Pharmaceuticals Inc LGND Indirect Beneficial Ow... 2009-07-01 15,169,950 2009-07-01 45,509,850    Premium*  
            Curis Inc CRIS Indirect Beneficial Ow... 2009-02-03 8,921,716 2009-04-27 5,951,716    Premium*  
            Repligen Corp RGEN Indirect Beneficial Ow... 2009-07-07 2,765,050 2009-07-07 8,295,150    Premium*  
            Gyre Therapeutics GYRE Indirect Beneficial Ow... 2009-10-16 2,061,925 2009-10-16 6,185,775    Premium*  
* Premium Members only  

Records found :    195         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 7 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-03-18 4 B $4.96 $759,110 I/I 153,000 4,831,500 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-11-19 4 B $2.65 $780,194 I/I 294,413 11,903,173 1.5 -
DVAX Dynavax Technologies Corp Direct Beneficial Owner   –       –       •   2009-08-05 4 S $2.00 $793,624 D/D (396,000) 5,494,457 0 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-11-21 4 B $2.40 $816,524 I/I 340,900 12,244,073 1.5 -
NBIX Neurocrine Biosciences In... Direct Beneficial Owner   –       –       •   2010-03-25 4 S $2.70 $822,960 D/D (304,800) 5,452,747 0 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-01 4 B $5.00 $825,528 I/I 165,000 6,892,477 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2009-06-25 4 S $2.87 $842,150 D/D (291,393) 15,850,522 0 -
DVAX Dynavax Technologies Corp Indirect Beneficial Owner   –       –       •   2009-06-04 4 S $1.68 $847,037 D/D (505,000) 6,313,657 0 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-12-05 4 B $0.57 $872,425 I/I 1,530,572 10,008,871 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-21 4 B $4.95 $920,905 I/I 186,000 8,109,577 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-11-12 4 B $2.45 $923,650 I/I 377,000 11,608,760 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-11-11 4 B $2.25 $927,450 I/I 412,200 11,231,760 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-04 4 B $5.08 $1,068,085 I/I 210,100 7,102,577 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-03-10 4 B $4.89 $1,100,655 I/I 225,000 4,498,000 1.5 -
NBIX Neurocrine Biosciences In... Indirect Beneficial Owner   –       –       •   2008-10-10 4 B $2.72 $1,215,968 I/I 447,047 5,658,647 1.5 -
SGXP Sgx Pharmaceuticals, Inc. Indirect Beneficial Owner   –       –       •   2008-07-10 4 B $3.03 $1,221,615 I/I 403,200 5,495,174 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-08 4 B $4.98 $1,289,406 I/I 259,000 7,729,877 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-10-16 4 B $0.65 $1,320,150 I/I 2,031,000 7,827,799 1.5 -
AMAG AMAG Pharmaceuticals Inc officerTitle   –       –       •   2006-01-13 4 S $15.40 $1,350,580 I/I (87,700) 1,028,733 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2009-06-26 4 S $2.93 $1,402,974 D/D (479,256) 15,371,266 0 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-10 4 B $4.26 $1,415,268 I/I 324,227 5,930,777 1.5 -
SGXP Sgx Pharmaceuticals, Inc. Indirect Beneficial Owner   –       –       •   2008-06-18 4 B $1.45 $1,602,623 I/I 1,105,257 4,209,574 1.5 -
NPSP NPS Pharmaceuticals Inc Indirect Beneficial Owner   –       –       •   2008-09-19 4 S $8.55 $1,638,621 I/I (191,600) 4,666,315 0 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-02-07 4 B $4.90 $1,803,970 I/I 368,300 7,470,877 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-01-31 4 B $4.71 $2,404,548 I/I 510,000 6,727,477 1.5 -
  195  Records found
  1   2   3   4   5   6   7  8      
  Page 7 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us